Figure 2.
Anti-SARS-CoV-2 S1/S2 levels distribution among cancer patients with solid tumors treated with chemotherapy, immunotherapy, neither, or both.
Chemo, chemotherapy; immune, immunotherapy.
Anti-SARS-CoV-2 S1/S2 levels distribution among cancer patients with solid tumors treated with chemotherapy, immunotherapy, neither, or both.
Chemo, chemotherapy; immune, immunotherapy.